Trials / Recruiting
RecruitingNCT05940272
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Evaluation of a Communication Intervention (Hematolo-GIST) for Large B-Cell Lymphoma Providers
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to develop and test a new communication training intervention called Hematolo-GIST to help oncologists communicate with patients about their lymphoma diagnosis and advance care planning.
Conditions
- Lymphoma, B-Cell
- Lymphoma
- Large-cell Lymphoma
- Large B-cell Lymphoma
- DLBCL - Diffuse Large B Cell Lymphoma
- Mediastinal B-Cell Diffuse Large Cell Lymphoma
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Hematolo-GIST Training | Hematologist will participate in a group Hematolo-GIST training provided remotely via the study team. |
| BEHAVIORAL | Participants Appointment | Participants will meet with Hematolo-GIST trained hematologists. Participants will consent to having their appointment audio-recorded on password-protected devices or MSK approved secure platforms. |
Timeline
- Start date
- 2023-07-03
- Primary completion
- 2028-07-03
- Completion
- 2028-07-03
- First posted
- 2023-07-11
- Last updated
- 2025-10-09
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05940272. Inclusion in this directory is not an endorsement.